Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms announces it has successfully completed the StrixNB™ pilot dog efficacy study using the VOHC (Veterinary Oral Health Council) recommended test protocol.
15-05-2012 Read More
Medicure Inc. ("Medicure" or the "Company") (pinksheets:MCUJ) is pleased to announce the commencement of enrollment in SAVI-PCI ("Shortened Aggrastat Versus Integrilin in Percutaneous Coronary Intervention") a prospective, multicenter, randomized clinical trial of its commercial product, AGGRASTAT(R) (tirofiban HCl), in the United States.
11-05-2012 Read More
Monteris secured financing to support the continued commercialization of the NeuroBlate(TM) System
08-05-2012 Read More
Wound gel reduced over 95% of biofilm-embedded bacteria versus approximately 50% reduction by industry leading product. Superior performance is due to synergy between DispersinB® and antimicrobial peptide
23-04-2012 Read More
Seasoned Medical Executive Selected to Drive Commercialization of Promising Medical Technology for the Treatment of Brain Tumors
18-04-2012 Read More
Ottawa, (March 15, 2012) – The Honourable Leona Aglukkaq, Minister of Health, announced today a renewed partnership between the Government of Canada and Canada’s Research-Based Pharmaceutical Companies (Rx&D) to strengthen clinical research in Canada.
19-03-2012 Read More
A grand new plan for the Manitoba Venture Challenge will be introduced at an event hosted by a new entity called Innovate Manitoba
15-03-2012 Read More
The University of Manitoba will have to go back to the drawing board to find someone to lead its Technology Transfer Office.
15-03-2012 Read More
A researcher from St. Boniface Hospital has found a gene that could bring damaged heart tissue back to life.
02-03-2012 Read More
For a business incubator such as Biomedical Commercialization Canada, a guy like Ed Richmond is a godsend.
01-03-2012 Read More